MiiCARE is a company that provides AI-based in-home companionship & health support for the elderly. miiCARE provides an 18-month product validation process with the NHS and the elderly. Its innovation miiCUBE is a cloud-based assistive technology solution that can detect an emergency and inform a designated responder. miiCARE already has 250 prospective clients who have already expressed interest to purchase the product. The company was accepted for the 'Microsoft for Startups' program in 2019 and Microsoft's 'AI for Good' acceleration cohort in 2020. The company will utilise the investments to create an emergency stock to support future orders, fulfill orders for clients, strengthen its team, and create a small inventory for orders.
days to go:
Expired
investment:
£354,632
Oyako is a distance-control application that aims to reduce the stresses and strains on children's eyes. The company asserts that an increase in mobile technology usage has led to an increase in myopia (nearsightedness) in children. It also leads to parents incurring a cost by way of purchasing spectacles along with a cost to the National Health Service (NHS) and medical insurance companies. By 2050, half of the global population will be short-sighted if current trends continue. Oyako aims to solve this issue through its application. Oyako's prototype app uses a simple traffic light design to signify safe or damaging scenarios, intelligently controls the phone camera without compromising battery usage, and is available on the App Store and Google Playstore. Oyako will use the investment to finalise its application and take it to market at £6.99 per download.
days to go:
Expired
investment:
£131,641
Vendoir aims to become the go-to app for instantly sourcing and booking event vendors on-demand with ease. It intends to operate as a marketplace model and earn revenue through commission on each transaction and via premium accounts. It asserts that it is part of the London & Partners Business Growth Programme Spring Cohort 2021. The company endeavours to disrupt the £43 billion UK events market post-Covid-19 with an on-demand app. It has a waitlist of more than 1300 interested clients and has featured in Forbes. The company will use the investment to accelerate its product launch.
days to go:
Expired
investment:
£172,457
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.
days to go:
Expired
investment:
£148,736
Felcana is a patented Eco-system of connected devices: Helix, Home Hub, Micro-Location Beacons and the Felcana application which work together to monitor the pet's (cat or dogs) well-being. This Digital Pet Health Platform tracks pet's behaviour and provides the vet, rich data leading to faster diagnosis and faster treatment. Felcana has been developed by a world-class team of vets and engineers and, it has been designed and tested by using the latest materials, designs, and techniques. Felcana has won the Design Spark Award in 2017. It is making unique partnerships with leading pet industries and the UK's largest pet health plan provider, the world's top-ranked vet school and The Royal Veterinary College. The new investment will enable it to grow consumer reach and accelerate its sales.
days to go:
Expired
investment:
£343,926
Commuter Club is a unique technological platform that brings together data, retailing and credit to save commuters hassle, time and money. It helps commuters purchase and find the right tickets for their commute by an online journey, and provide big savings on annual tickets through a convenient, low-cost, monthly payment plan. Till date, it has issued £70mn+ in loans to over 20,000 customers and realized a CAGR revenue growth rate of 300% (2014 - 2018). Now with attractive unit economics, great customer lifetime value, proven acquisition mode, and improving margins with scale, it expects to issue tens of millions in loans and tickets this year. Additionally, it has expanded its corporate solution to leading clients like Pret a Manger, Monzo, and Hakkasan. It is raising capital to continue to fund its growth and acquire customers, develop its technological platform, up skill its team and reach profitability in 2020.
days to go:
Expired
investment:
£2,331,000
Nikalyte is a specialist in nanoparticles research and development (R&D) as well as commercialisation in various application areas such as cell binding, cell separation, drug delivery, catalysis, nano-photonics, and electrochemistry. The company is developing a nanoparticle generator, which will enable researchers to produce nanoparticles of almost any metal or alloy on almost any substrate via a user-friendly interface. Nikalyte is offering free nanoparticle samples to researchers investigating antiviral materials, such as Copper and Silver, towards developing a vaccine for Covid-19. The company also offers a consultancy service that provides advice on nanoparticle applications and ultra-high vacuum systems. The company aims to use the investment to scale its business.
days to go:
Expired
investment:
Withheld
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go:
Expired
investment:
Withheld
GoCustomate has an aim to get rid of the pain points for the SME's when buying and selling by completely changing the way transactions occur. Till date, they have secured the licence to utilize third-party eMoney authorization from the Central Bank of Ireland, GoCustomate verifies its users, provides automated payment schedules and flexible escrow wallets. It also protects customers with their unique digital wallets. The company is fundraising to grow sales by focusing on SME customers with relevant pain points. With the proceeds, the company will expand across the EU and Australia.
days to go:
Expired
investment:
£156,300
